Abstract:To the Editor: Type 2 diabetes (T2D) is one of the most common and fastest growing non-communicable diseases worldwide. Sex hormone-binding globulin (SHBG) is a circulating homodimeric glycoprotein that can bind androgens and estrogens with high affinity in blood and regulate their bioavailability.[1] Emerging evidence has shown that low levels of SHBG are associated with T2D.[2] Genetic factors are important factors that affect the development of T2D. However, the combined effect of SHBG and genetic factors on T2D risk is largely unknown. In the current study, we analyzed data from the Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China) to evaluate whether SHBG levels could interact with genetic predisposition to increase the T2D risk in men and postmenopausal women and examined the joint association of SHBG and genetic predisposition with T2D. The data were from the SPECT-China study from February 2014 to May 2016. Subjects who were 18–80 years old (n = 12,666) were recruited. Men and postmenopausal women (n = 9423) were eligible for inclusion. Participants who had missing information on more than two single nucleotide polymorphism (SNP) genotypes (n = 1618), missing SHBG data (n = 330), or use of estrogen replacement therapy (n = 0) were excluded. Finally, this study included a total of 7475 men and postmenopausal women. The workflow of this research is shown in Supplementary Figure 1, https://links.lww.com/CM9/B654. The study received approval from the Ethics Committee of Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine (No. SH9H-2013-86). Written informed consent was obtained from all study participants. Demographic characteristics, lifestyle risk factors, bodyweight, height, blood pressure, interviews, and collection of biological specimens at each site were collected with a uniform assessment protocol, and blood samples were obtained in a central laboratory as before.[3] Eighteen SNPs associated with T2D and identified from large-scale GWASs and meta-analyses in East Asians were selected[3] [Supplementary Table 1, https://links.lww.com/CM9/B654], and then we successfully constructed a weighted diabetes genetic risk score in Chinese adults using an additive model. Logistic regression models were used to examine the association of SHBG and genetic risk with T2D in men and postmenopausal women. The interaction analysis between SHBG quartiles and diabetes genetic-risk tertiles was performed. All analyses were two-sided. P-values <0.05 indicated significant differences. In the current study, 4050 men and 3425 postmenopausal women were included. The baseline characteristics are presented in Supplementary Table 2, https://links.lww.com/CM9/B654. After multivariable adjustment in Model 3, there was a significant inverse relationship between SHBG quartiles and diabetes [Supplementary Table 3, https://links.lww.com/CM9/B654]. The relationship remained significant after further adjustment for diabetes genetic risk score. Each 1-standard deviation (SD) decrease in log-serum SHBG was associated with a 4% increased risk of diabetes in men and a 132% increased risk of diabetes in postmenopausal women in Model 4. We also found a positive association between weighted genetic risk-score tertiles and diabetes in both men and postmenopausal women (Supplementary Table 4, https://links.lww.com/CM9/B654). Each 1-SD increase in the genetic risk score was associated with a 23% increased risk of diabetes both in men and in postmenopausal women in Model 4. When considered jointly, the highest odds of diabetes were observed in high genetic-risk participants with the lowest SHBG quartile [Figure 1]. Compared with low genetic-risk participants with the highest quartile of SHBG, the lowest SHBG quartile was associated with adjusted odd ratios (ORs) (95% confidence interval [CIs]) of 3.78 (2.23, 6.42) among those at low genetic risk, 4.33 (2.58, 7.26) among those at intermediate genetic risk, and 6.03 (3.59, 10.12) among those at high genetic risk in men. The corresponding adjusted ORs (95% CIs) in postmenopausal women were 5.50 (3.18, 9.49), 6.35 (3.69, 10.95), and 8.12 (4.75, 13.88), respectively. There were no significant interactions between the SHBG quartiles and genetic risk (all Pinteraction >0.05). The sensitivity analyses using unweighted genetic risk-score tertiles showed similar results [Supplementary Table 5, https://links.lww.com/CM9/B654].Figure 1: Multivariable-adjusted ORs (95% CI) for T2D according to the quartiles of SHBG and weighted genetic risk in men (A) and postmenopausal women (B). Participants at the highest quartile of SHBG with low genetic risk served as the reference group. The models were adjusted for age, education level, smoking status, drinking status, family history of diabetes, BMI, SBP, total cholesterol, and ln-total testosterone. BMI: Body mass index; CI: Confidence interval; ORs: Odds ratios; SBP: Systolic blood pressure; SHBG: Sex hormone-binding globulin; T2D: Type 2 diabetes.In the current study, we found that lower serum SHBG levels were significantly associated with an increased T2D risk in Chinese men and postmenopausal women regardless of genetic risk status. Genetic susceptibility and SHBG might exert an additive effect on T2D development. Our study extends the existing evidence showing an inverse association between SHBG levels and T2D risk.[4] Our findings reported that compared with those at low genetic risk with high SHBG levels, participants with both a high genetic risk and low SHBG levels had the highest T2D risk. These results support the notion that low SHBG levels may increase predisposition to T2D in adulthood regardless of genetic risk, which implies the importance of maintaining a healthy lifestyle for the prevention of T2D in those with low SHBG levels. Alternatively, intensive measures may target populations with high genetic risk and low SHBG levels. Several potential mechanisms underlying the association between low SHBG levels and T2D later in life have been proposed. Previous studies indicated that circulating SHBG is predictive of the degree of insulin resistance and glycemia at the 6-year follow-up.[5] Mendelian randomization results suggested that SHBG is a hepatokine involved in the pathogenesis of T2D in women.[5] The exact role of SHBG in the development of T2D remained to be clarified. However, our study also has several limitations. First, it has a cross-sectional design, and we could not draw conclusions regarding the causal relationship between serum SHBG and diabetes prevalence. Second, we constructed a genetic risk score based on only 18 common SNP genotypes, which may not fully reflect the genetic profile of diabetes. Moreover, since the present analyses were performed in Chinese individuals using SNPs identified in East Asians, our results might not be directly generalizable to other ethnic groups. Finally, information on several factors potentially affecting diabetes risk, such as maternal health and adult dietary patterns, was not collected. Therefore, the possibility of residual confounding cannot be ruled out. In conclusion, independent of the genetic risk score, lower serum SHBG levels were significantly associated with an increased T2D risk in Chinese men and postmenopausal women. Further studies are needed to investigate the causal relationship and the underlying mechanisms. Funding This work was supported by grants from the National Natural Science Foundation of China (No. 82120108008), Science and Technology Commission of Shanghai Municipality (Nos. 22015810500, 20015800400). Conflicts of interest None.

Definition, Prevalence, and Risk Factors of Low Sex Hormone-Binding Globulin in US Adults

Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women

Associations of Sex Hormone-binding Globulin with Bone Mineral Density Among US Adults, NHANES 2013–2016

The Advance in the Study on SHBG and Insulin Resistant

Association between sex hormone-binding globulin and kidney function in men

Association Between Sex Hormone-Binding Globulin and Kidney Function in Men: Results from the SPECT-China Study

Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China.

Physiological role and clinical significance of sex hormone binding globulin in men.

Association between sex hormone binding globulin and metabolic syndrome in US adults: insights from National Health and Nutrition Examination Survey (NHANES) 2013–2016

Sex Hormone-Binding Globulin, Genetic Susceptibility, and the Risk of Type 2 Diabetes in Men and Postmenopausal Women

Nonlinear association of sex hormone-binding globulin levels and chronic kidney disease, an analysis based on the National Health and Nutrition Examination Survey (NHANES) 2013–2016

Genetically Predicted Sex Hormone-Binding Globulin and Bone Mineral Density: A Mendelian Randomization Study

Sex Hormone-Binding Globulin and Arthritis: a Mendelian Randomization Study

Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms

Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease.

Low Level of Serum Sex Hormone Binding Globulin is Associated with the Occurrence of Metabolic Syndrome

SHBG gene polymorphisms and their influence on serum SHBG, total and free testosterone concentrations in men.

Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

Serum Sex Hormone-Binding Globulin is Associated with Symptomatic Late-Onset Hypogonadism in Aging Rural Males: a Community-Based Study

Concentrations of endogenous sex steroid hormones and SHBG in healthy postmenopausal women

Low Sex Hormone-Binding Globulin Levels Associate with Prediabetes in Chinese Men Independent of Total Testosterone